These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33544840)

  • 1. Intraarterial Degradation of Calcium Hydroxylapatite Using Sodium Thiosulfate - An In Vitro and Cadaveric Study.
    Yankova M; Pavicic T; Frank K; Schenck TL; Beleznay K; Gavril DL; Green JB; Voropai D; Robinson DM; Cotofana S
    Aesthet Surg J; 2021 Apr; 41(5):NP226-NP236. PubMed ID: 33544840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Analysis of the Degradation of Calcium Hydroxylapatite Dermal Filler: A Proof-of-Concept Study.
    Robinson DM
    Dermatol Surg; 2018 Nov; 44 Suppl 1():S5-S9. PubMed ID: 30358629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium hydroxylapatite: A review on safety and complications.
    Kadouch JA
    J Cosmet Dermatol; 2017 Jun; 16(2):152-161. PubMed ID: 28247924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of calcium hydroxylapatite in the upper third of the face: Retrospective analysis of techniques, dilutions and adverse events.
    Van Loghem JAJ
    J Cosmet Dermatol; 2018 Dec; 17(6):1025-1030. PubMed ID: 30362225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining topical dermal infused exosomes with injected calcium hydroxylapatite for enhanced tissue biostimulation.
    Chernoff G
    J Cosmet Dermatol; 2023 Mar; 22 Suppl 1():15-27. PubMed ID: 36988469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2).
    Emer J; Sundaram H
    J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biostimulating fillers and induction of inflammatory pathways: A preclinical investigation of macrophage response to calcium hydroxylapatite and poly-L lactic acid.
    Nowag B; Schäfer D; Hengl T; Corduff N; Goldie K
    J Cosmet Dermatol; 2024 Jan; 23(1):99-106. PubMed ID: 37593832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Sodium Thiosulfate Act as a Reversal Agent for Calcium Hydroxylapatite Filler? Results of a Preclinical Study.
    Danysz W; Nowag B; Hengl T; Kreymerman P; Furne C; Madeuf E; Höennscheidt C; Mraz Robinson D
    Clin Cosmet Investig Dermatol; 2020; 13():1059-1073. PubMed ID: 33408497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsurgical Chin and Jawline Augmentation Using Calcium Hydroxylapatite and Hyaluronic Acid Fillers.
    Moradi A; Shirazi A; David R
    Facial Plast Surg; 2019 Apr; 35(2):140-148. PubMed ID: 30943558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus.
    van Loghem J; Funt D; Pavicic T; Goldie K; Yutskovskaya Y; Fabi S; Siebenga P; Thuis J; Hkeik J; Kadouch J; Prager W; Azib N; Casabona G; Dayan S; Bay Aguilera S; Snozzi P; Saeed P
    J Cosmet Dermatol; 2020 Nov; 19(11):2845-2858. PubMed ID: 32185876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of polycaprolactone and calcium hydroxylapatite dermal fillers in a rat model.
    Yanatma I; Sarac G; Gul M; Gul S; Kapicioglu Y
    Dermatol Ther; 2021 Jan; 34(1):e14716. PubMed ID: 33368862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a suitable layer for injecting calcium hydroxylapatite fillers in the hands.
    Kim JS; Lee W; Oh W; Park JA; Yang EJ
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):866-873. PubMed ID: 33214113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler.
    Yutskovskaya Y; Kogan E; Leshunov E
    J Drugs Dermatol; 2014 Sep; 13(9):1047-52. PubMed ID: 25226004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium hydroxylapatite filler: an overview of safety and tolerability.
    Pavicic T
    J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-Label, Post-Marketing Study to Evaluate the Performance and Safety of Calcium Hydroxylapatite With Integral Lidocaine to Correct Facial Volume Loss.
    Muti GF
    J Drugs Dermatol; 2019 Jan; 18(1):86-91. PubMed ID: 30681803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium hydroxylapatite microspheres activate fibroblasts through direct contact to stimulate neocollagenesis.
    Nowag B; Casabona G; Kippenberger S; Zöller N; Hengl T
    J Cosmet Dermatol; 2023 Feb; 22(2):426-432. PubMed ID: 36575882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CALCIUM HYDROXYLAPATITE MICROSPHERES - BIOCOMPATIBILITY AND CLINICAL EFFECTS.
    Wollina U; Wiegand C; Hipler UC
    Georgian Med News; 2018 May; (278):62-68. PubMed ID: 29905547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheological Properties of Calcium Hydroxylapatite With Integral Lidocaine.
    Meland M; Groppi C; Lorenc ZP
    J Drugs Dermatol; 2016 Sep; 15(9):1107-10. PubMed ID: 27602973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Dimensional Changes in the Midface Following Malar Calcium Hydroxyapatite Injection in a Cadaver Model.
    Gatherwright JR; Brown MS; Katira KM; Rowe DJ
    Aesthet Surg J; 2015 Aug; 35(6):NP169-75. PubMed ID: 25969435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiochemical Characteristics of Calcium Hydroxylapatite (CaHA).
    Lorenc ZP; Bass LM; Fitzgerald R; Goldberg DJ; Graivier MH
    Aesthet Surg J; 2018 Apr; 38(suppl_1):S8-S12. PubMed ID: 29897516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.